THE CHOLANGIOCARCINOMA FOUNDATION
Income Statement
Fiscal Year Start:
Jul 1
Revenues in 2025
$7,130,406
Contributions
93%
Program Services
5%
Investments
2%
Other
<1%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Expenses in 2025
$7,195,778
Salaries & Benefits
49%
Other
14%
Grants
14%
Fees to Service Providers
12%
Offices, Occupancy & IT
8%
Advertising & Promotion
2%
Depreciation
<1%
Benefits to Members
0%
Interest
0%
Revenues
2024
2025
Change
Contributions
$6,140,280
$6,634,735
+8%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$640,676
$357,617
-44%
Membership Dues
$0
$0
-
Investments
$173,128
$133,333
-23%
Other
-$35,458
$4,721
-113%
Total Revenues
$6,918,626
$7,130,406
+3%
Expenses
2024
2025
Change
Grants
$1,012,601
$1,015,000
+0%
Benefits to Members
$0
$0
-
Salaries & Benefits
$2,998,050
$3,515,927
+17%
Fees to Service Providers
$662,635
$834,985
+26%
Advertising & Promotion
$94,533
$140,667
+49%
Offices, Occupancy & IT
$484,563
$604,264
+25%
Interest
$0
$0
-
Depreciation
$36,377
$44,684
+23%
Other
$949,165
$1,040,251
+10%
Total Expenses
$6,237,924
$7,195,778
+15%
Net income
2024
2025
Change
Net income
+$680,702
-$65,372
-110%
Functional Expenses
Summary
2024
2025
Change
Program
$4,656,237
$5,376,715
+15%
Admin
$416,214
$492,993
+18%
Fundraising
$1,165,473
$1,326,070
+14%
Total Expenses
$6,237,924
$7,195,778
+15%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)